CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 2.0  0.8%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3259th / 3893

TABLE-CellSeed - 9-MTH group results

Mon 13th November, 2017 6:30am
Nov 13 (Reuters)-  
             CellSeed Inc.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to    
                Sep 30, 2017        Sep 30, 2016       Dec 31, 2017   
                   LATEST             YEAR-AGO            LATEST      
                   RESULTS             RESULTS           FORECAST     
  Sales            42 mln              36 mln            100 mln      
                 (+15.0 pct)         (-6.4 pct)        (+99.3 pct)    
  Operating     loss 740 mln        loss 701 mln        loss 1.25     
  Recurring     loss 674 mln        loss 691 mln        loss 1.23     
  Net           loss 674 mln        loss 689 mln        loss 1.23     
  EPS          loss 67.46 yen      loss 75.81 yen    loss 135.66 yen  
  Ann Div                                NIL               NIL        
  -Q2 div            NIL                 NIL                          
  -Q4 div                                NIL               NIL        
   
  NOTE - CellSeed Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T 
  ((Tokyo Headline News Desk +813 6441 1812))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.